New HKEx Guidance for Biotech Companies Listing under Chapter 18A

Clinton MorrowPartner, Charltons

The Hong Kong Stock Exchange (HKEx) issued new and updated guidance letters in April 2020 to assist pre-revenue Biotech companies applying to list under Chapter 18A of the Main Board Listing Rules (Chapter 18A). The latest guidance follows a review by HKEx of how Chapter 18A operates and comprises:

Read More…


Links